RE:RE:RE:RE:RE:RE:Auxly valued at $4 - $7 if you read articleAnd if that is how you feel then you are entitle to that opinon.
I think most of what XLY has told its investors has happened so far and the things that have not happened like the FSD pharma deal, have been because of unknown circumstances not dishonesty.
I think a lot of the misconception around things changes comes from the fact that the industry adopted a standard of reporting funded capacity. When they first started reporting possible production it was based on full expantion of all projects even those that were not started or funded, which was standard pratice at the time. Now they are only reporting capacity that is fully funded. For Example FSD had plans for a phase 2 and phase three. only phase 2 that had started being built and XLY had the money in the bank to fund would have been included in funded capacity, previosly they would have also included the Phase three expanstion in the numbers which would have added a couple hundread thousand KGS. I think funded capacity is a good way for things to be reported.
Based on funded capacity XLY ranks 4th only behind WEED, ACB and APH. That is not a number that can really be manipulated as it is based on known consrtuction, that has already started and if fully funded.
IO do not think XLY should be the 4th most valuble company because of that because several companies that have less funded capacity have either more proven distribution then XLY like OGI for example or a large well know US companies investment, HEXO for example. But I do think they should be in the top 10 for Market Cap and they are not even there.